Literature DB >> 10543871

Antimalarial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers.

G H Posner1, P Ploypradith, M H Parker, H O'Dowd, S H Woo, J Northrop, M Krasavin, P Dolan, T W Kensler, S Xie, T A Shapiro.   

Abstract

Nine C-10 non-acetal derivatives of the natural trioxane artemisinin (1) were prepared as dimers using some novel chemistry. As designed, each dimer was stable chemically. C-10 Olefinic dimers 7 and C-10 saturated dimers 8-13 all showed good to excellent antimalarial and antiproliferative activities in vitro. Dimers 8, 10, and 12 were especially potent and selective at inhibiting growth of some human cancer cell lines in the NCI in vitro 60-cell line assay.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10543871     DOI: 10.1021/jm990363d

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  18 in total

1.  Cytotoxic small molecule dimers and their inhibitory activity against human breast cancer cells.

Authors:  M Kyle Hadden; Brian S J Blagg
Journal:  Bioorg Med Chem Lett       Date:  2007-07-13       Impact factor: 2.823

2.  QSAR for anti-malarial activity of 2-aziridinyl and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives.

Authors:  Mohamed Zahouily; Mohamed Lazar; Abdelhakim Elmakssoudi; Jamila Rakik; Sanaa Elaychi; A Rayadh
Journal:  J Mol Model       Date:  2005-12-09       Impact factor: 1.810

3.  Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax.

Authors:  Blake S Moses; Samantha McCullough; Jennifer M Fox; Bryan T Mott; Søren M Bentzen; MinJung Kim; Jeffrey W Tyner; Rena G Lapidus; Ashkan Emadi; Michelle A Rudek; Tami J Kingsbury; Curt I Civin
Journal:  Blood Adv       Date:  2021-02-09

4.  Dinitroaliphatics as linkers: application in the synthesis of novel artemisinin carba-dimer.

Authors:  Abhishek Goswami; Partha Pratim Saikia; Bishwajit Saikia; Nabin C Barua
Journal:  Mol Divers       Date:  2011-01-04       Impact factor: 2.943

5.  pH-responsive artemisinin dimer in lipid nanoparticles are effective against human breast cancer in a xenograft model.

Authors:  Yitong J Zhang; Xi Zhan; Liguo Wang; Rodney J Y Ho; Tomikazu Sasaki
Journal:  J Pharm Sci       Date:  2015-03-09       Impact factor: 3.534

6.  Synthesis of Artemisinin-Estrogen Hybrids Highly Active against HCMV, P. falciparum, and Cervical and Breast Cancer.

Authors:  Tony Fröhlich; Anita Kiss; János Wölfling; Erzsébet Mernyák; Ágnes E Kulmány; Renáta Minorics; István Zupkó; Maria Leidenberger; Oliver Friedrich; Barbara Kappes; Friedrich Hahn; Manfred Marschall; Gyula Schneider; Svetlana B Tsogoeva
Journal:  ACS Med Chem Lett       Date:  2018-10-19       Impact factor: 4.345

7.  Antimalarial chemotherapy: artemisinin-derived dimer carbonates and thiocarbonates.

Authors:  Jennifer R Mazzone; Ryan C Conyers; Abhai K Tripathi; David J Sullivan; Gary H Posner
Journal:  Bioorg Med Chem Lett       Date:  2014-04-16       Impact factor: 2.823

8.  Synthesis and antimalarial efficacy of two-carbon-linked, artemisinin-derived trioxane dimers in combination with known antimalarial drugs.

Authors:  Bryan T Mott; Abhai Tripathi; Maxime A Siegler; Cathy D Moore; David J Sullivan; Gary H Posner
Journal:  J Med Chem       Date:  2013-03-07       Impact factor: 7.446

9.  Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers.

Authors:  Ravit Arav-Boger; Ran He; Chuang-Jiun Chiou; Jianyong Liu; Lauren Woodard; Andrew Rosenthal; Lorraine Jones-Brando; Michael Forman; Gary Posner
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

10.  Unique and highly selective anticytomegalovirus activities of artemisinin-derived dimer diphenyl phosphate stem from combination of dimer unit and a diphenyl phosphate moiety.

Authors:  Ran He; Michael Forman; Bryan T Mott; Rajkumar Venkatadri; Gary H Posner; Ravit Arav-Boger
Journal:  Antimicrob Agents Chemother       Date:  2013-06-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.